Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
RHCE Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Clone Names | 100617261 |
|---|
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
|---|---|
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The Rh blood group system is the second most clinicallysignificant of the blood groups, second only to ABO. It is also themost polymorphic of the blood groups, with variations due todeletions, gene conversions, and missense mutations. The Rh bloodgroup includes this gene which encodes both the RhC and RhEantigens on a single polypeptide and a second gene which encodesthe RhD protein. The classification of Rh-positive and Rh-negativeindividuals is determined by the presence or absence of the highlyimmunogenic RhD protein on the surface of erythrocytes. A mutationin this gene results in amorph-type Rh-null disease. Alternativesplicing of this gene results in four transcript variants encodingfour different isoforms.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Hue-Roye, K., et al. Vox Sang. 98 (3 PT 1), E263-E268 (2010) :Schmid, P., et al. Transfusion 50(1):267-269(2010)Hipsky, C.H., et al. Immunohematology 26(2):57-59(2010)Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Shipping Information
